Mead Johnson & Company LLC history

North of the border, in Canada, he placed a sales agent in 1907.

Mead Johnson & Company introduced its first major infant feeding product in 1910 and followed it the next year with the product that would set the company on its path to leadership in infant and children's nutrition.

After much research and successful clinical testing, Dextri-Maltose was introduced in 1911.

In 1915, the company settled in Evansville, Indiana, where still it maintains its largest presence, including a Pediatric Nutrition Institute research facility and a manufacturing plant.

Johnson moved production of Dextri-Maltose to Evansville in 1916.

The next few years were difficult due to start-up costs and mechanical problems, but by 1920 the company was again solvent and poised for growth.

Fifteen years later, in 1922, he rented manufacturing space in Toronto, Ontario, and established a separate Canadian organization.

Vitamin research resulted in the introduction of a series of oils that contained vitamin D, beginning with Mead's Standardized Cod Liver Oil in 1924.

Also in 1925, in January, the company opened its newly built laboratory in Evansville and continued its product research.

In 1935 the company introduced Oleum Percomorphum, which would prove to be its most successful product during the decade surrounding World War II. O.P., as doctors called it, was a vitamin A and D supplement that further reduced the cost of preventing rickets.

Mead Johnson's vitamin research continued to advance with the introduction of Oleum Percomorphum syrup, valued as a source of vitamin D, which prevented rickets, and also provided a source of vitamin A. In 1936, Oleum Percomorphum in capsule form was introduced at the request of physicians.

Nutramigen, the first infant formula for the nutritional management of cow's milk allergy, was launched in 1942.

With growth in mind, in 1952 Lambert Johnson embarked upon an expanded program of research and development, pertaining also to pharmaceutical products.

Cytoxan (1959) was Mead Johnson's first chemotherapeutic agent.

Mucomyst (1963) was a life-saving advance in bronchopulmonary medicine.

Introduced in 1964, Nursette bottles revolutionized infant feeding in the United States by providing Enfamil in new ready-to-use bottles, sterilized nipples - offering nourishment for children and convenience for their parents.

Although it would come to be popular among physicians and parents throughout the world, Enfamil was the subject of a "product recall" in March 1967.

In the infant formula arena, it introduced Pregestimil (1971) for infants unable to absorb fats properly.

Because of success in both of Mead Johnson's business lines (nutritional and pharmaceutical) the company was reorganized in 1978 into the Mead Johnson Nutritional Division and Mead Johnson Pharmaceutical Division.

Bristol-Myers' merger with Squibb Corporation in 1989 was to bring more change in the structure of the organization.

Meanwhile, in 1990 Mead Johnson's nutritional businesses in 19 countries were integrated with its United States business to form Mead Johnson's first global organization in 25 years.

In 1995, Mead Johnson completed construction of a manufacturing plant in China, having established business there and in Vietnam, and it expanded into Central and Eastern Europe.

In January 1999, Mead Johnson introduced VIACTIV Soft Calcium Chews, a chewable calcium supplement for women aged 35 and over.

Another major recall occurred in 2001, when preparation instructions were translated incorrectly into Spanish and printed on the labels of some 3.7 million cans of powder Nutramigen formula and 930,000 32-ounce cans of the ready-to-use version.

Introduction of Enfamil LIPIL in the United States In 2002, Enfamil LIPIL was introduced as the first infant formula in the United States to include DHA and ARA, nutrients important for brain and eye development.

In 2003 Mead Johnson purchased OPR Development, L.P.'s Cafcit (caffeine citrate) Injection and Oral Solution.

"Novartis Completes Mead Acquisition," Nutraceuticals International, March 2004.

Although Asia represented a significant growth opportunity for the company, it also proved problematic when, in February 2006, China's quarantine authority ordered a ban on faulty milk powder Mead Johnson had produced.

In 2009, Enfamil PREMIUM infant formula with Triple Health Guard™ was introduced to the United States to promote healthy brain and eye development.